Estrogen replacement therapy and the risk of endometrial cancer: remaining controversies.

[1]  P M Layde,et al.  The evaluation of the data collection process for a multicenter, population-based, case-control design. , 1988, American journal of epidemiology.

[2]  P. Wingo,et al.  ORAL CONTRACEPTIVES AND BREAST CANCER IN YOUNG WOMEN , 1986, The Lancet.

[3]  S. Shapiro,et al.  Risk of localized and widespread endometrial cancer in relation to recent and discontinued use of conjugated estrogens. , 1985, The New England journal of medicine.

[4]  P. Hartge,et al.  Random digit dialing in selecting a population-based control group. , 1984, American journal of epidemiology.

[5]  J. Kelsey,et al.  A case-control study of cancer of the endometrium. , 1982, American journal of epidemiology.

[6]  N. Weiss,et al.  Survival among women with endometrial cancer: a comparison of estrogen users and nonusers. , 1982, American journal of obstetrics and gynecology.

[7]  C. la Vecchia,et al.  Oestrogens and obesity as risk factors for endometrial cancer in Italy. , 1982, International journal of epidemiology.

[8]  P. Macdonald.  Estrogen plus progestin in postmenopausal women. , 1981, The New England journal of medicine.

[9]  M. Whitehead,et al.  Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. , 1981, The New England journal of medicine.

[10]  R. Spengler,et al.  Exogenous estrogens and endometrial cancer: a case-control study and assessment of potential biases. , 1981, American journal of epidemiology.

[11]  J. Collins,et al.  Oestrogen and Endometrial Cancer: A Reappraisal , 1981, Journal of the Royal Society of Medicine.

[12]  A. Donner,et al.  A comparison of estrogen use by women with endometrial cancer, gynecologic disorders, and other illnesses. , 1981, American journal of obstetrics and gynecology.

[13]  J. Elwood,et al.  Clinical and pathological features and survival of endometrial cancer patients in relation to prior use of estrogens. , 1980, Gynecologic oncology.

[14]  S. Shapiro,et al.  Recent and past use of conjugated estrogens in relation to adenocarcinoma of the endometrium. , 1980, The New England journal of medicine.

[15]  R. Gambrell,et al.  Use of the Progestogen Challenge Test to Reduce the Risk of Endometrial Cancer , 1980, Obstetrics and gynecology.

[16]  C. C. Pulliam,et al.  Estrogen and endometrial cancer: cases and two control groups from North Carolina. , 1980, American journal of obstetrics and gynecology.

[17]  J. Studd,et al.  Endometrial disease after treatment with oestrogens and progestogens in the climacteric. , 1980, British medical journal.

[18]  J. Studd,et al.  The Prevention and Treatment of Endometrial Pathology in Postmenopausal Women receiving Exogenous Estrogens , 1980 .

[19]  S. Robboy,et al.  Changing Trends and Prognostic Features in Endometrial Cancer Associated with Exogenous Estrogen Therapy , 1979, Obstetrics and gynecology.

[20]  A. Kreutner,et al.  Endometrial carcinoma: the effect of estrogens. , 1979, Gynecologic oncology.

[21]  D. English,et al.  Endometrial cancer in relation to patterns of menopausal estrogen use. , 1979, JAMA.

[22]  K. Rothman,et al.  Replacement estrogens and endometrial cancer. , 1979, The New England journal of medicine.

[23]  P. Stolley,et al.  Endometrial cancer and estrogen use. Report of a large case-control study. , 1979, The New England journal of medicine.

[24]  A. Feinstein,et al.  Alternative Analytic Methods for Case-Control Studies of Estrogens and Endometrial Cancer , 1978 .

[25]  M. Pike,et al.  Estrogens and endometrial cancer in a retirement community. , 1976, The New England journal of medicine.

[26]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.